Why are there no medicines for neglected tropical diseases?
PDF (Español (España))

How to Cite

Cañón-Montañez, W., & Rodríguez-Acelas, A. L. (2010). Why are there no medicines for neglected tropical diseases?. Médicas UIS, 23(2). Retrieved from https://revistas.uis.edu.co/index.php/revistamedicasuis/article/view/1444

Abstract

 

 

The article initially plants the discussions that have been given around the neglected tropical diseases, their characteristics and classification. In second instance, examines the prevalence, population at risk, affected regions and the associated mortality to these diseases. Finally, a critical analysis of the current state of the knowledge in issue of research for the development of medicines for the eradication and control of these diseases is presented. (MÉD.UIS. 2010;23(2):144-7).

 

Key words: Pharmaceutical Preparations. Disease. Tropical Climate. Poverty Areas.

PDF (Español (España))

References

1. Hotez PJ. The Biblical Diseases and U.S. Vaccine Diplomacy. The Brown Journal of World Affairs 2006, 12:2;247-58.

2. Yamey G. The world’s most neglected diseases. BMJ 2002;325:176-7.

3. Hotez PJ. Stigma: The Stealth Weapon of the NTD. PLoS Med 2008,2:4;e230.

4. Ehrenberg JP, Ault SK. Neglected diseases of neglected populations: thinking to reshape the determinants of health in Latin America and the Caribbean. BMC Public Health 2005; 5: 119.

5. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of the neglected tropical diseases. N Engl J Med 2007,357:1018-27.

6. Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD, Mills EJ. Health and human rights 3: neglected diseases, civil conflicts, and the right to health. Lancet 2007;370:619–27.

7. Reddy M, Gill SS, Kalkar SR, Anderson PJ, Rochon PA. Oral drug therapy for multiple neglected tropical diseases: a systematic review. JAMA 2007; 298: 1911–24.

8. PLoS Medicine Editors. A new era of hope for the world’s most neglected diseases. PLoS Med 2005;2:e323.

9. Moran M, Ropars A-L, Guzman J, Diaz J, Garrison C. The new landscape of neglected disease drug development. London: Wellcome Trust, 2005.

10. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public health policy failure. Lancet. 2002;359:2188–2194.

11. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Roses-Periago M. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008 Sep 24;2(9):e300.

12. Bitran R, Martorell B, Escobar L, Munoz R, Glassman A. Controlling and eliminating neglected diseases in Latin America and the Caribbean. Health Aff (Millwood), 2009 Nov-Dec;28(6):1707-19.

13. Nelson K. Stimulating research in the most neglected diseases. Lancet 2002;359:1042.

Downloads

Download data is not yet available.